Patents by Inventor Gotz Muench

Gotz Muench has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSION PROTEIN
    Publication number: 20130130315
    Abstract: An isolated nucleic acid molecule selected from the group consisting of: vi. a nucleic acid molecule comprising a nucleotide sequence which is at least 85% identical to the nucleotide sequence of SEQ ID NO:1 or a complement thereof; vii. a nucleic acid molecule comprising a fragment of at least 1500 consecutive nucleotides of the nucleotide sequence of SEQ ID NO:1, or a complement thereof; viii. a nucleic acid molecule which encodes a polypeptide comprising an amino acid sequence at least 85% identical to SEQ ID NO:2; ix. a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of SEQ ID NO:2, wherein the fragment comprises at least 500 contiguous amino acids of SEQ ID NO: 2; and x.
    Type: Application
    Filed: April 6, 2011
    Publication date: May 23, 2013
    Applicant: ADVANCECOR GMBH
    Inventors: Meinrad Gawaz, Tanja Schönberger, Heidrun Degen, Götz Münch, Hans-Peter Holthoff, Andreas Bültmann, Hans-Jörg Bühring, Christoph Leder
  • Antibodies which bind to epitopes of glycoprotein VI
    Patent number: 8119135
    Abstract: The present invention provides anti-thrombotic agents, methods for screening for said anti-thrombotics agents and methods of treating thrombotic and other cardiovascular disorders.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: February 21, 2012
    Assignees: Helmhotz Zentrum Munchen, Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH), Corimmun GmbH
    Inventors: Götz Münch, Meinrad Gawaz, Andreas Bültmann, Elisabeth Kremmer
  • Immunoadhesin comprising a glycoprotein VI domain
    Patent number: 7531178
    Abstract: The present invention provides a fusion protein comprising (1) the extracellular domain of glycoprotein VI or a variant thereof that is functional for binding to collagen and (b) the Fc domain of the immunoglobulin or a function-conservative part thereof, characterized by a polypeptide chain having an amino acid sequence as shown in FIG. 7 and whereby the fusion protein is obtainable by a process which provides the fusion protein in the form of a specific dimer.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: May 12, 2009
    Assignee: Trigen GmbH
    Inventors: Steffen Massberg, Meinrad Gawaz, Andreas Bültmann, Götz Münch, Martin Ungerer, Mario Peluso
  • Polynucleotides encoding immunoadhesins comprising a glycoprotein VI domain
    Patent number: 7514543
    Abstract: The present invention provides a fusion protein comprising (a) the extracellular domain of glycoprotein VI or a variant thereof that is functional for binding to collagen and (b) the Fc domain of an immunoglobulin or a function-conservative part thereof, characterised by a polypeptide chain having an amino acid sequence as shown in FIG. 7 and whereby the fusion protein is obtainable by a process which provides the fusion protein in the form of a specific dimer.
    Type: Grant
    Filed: June 5, 2003
    Date of Patent: April 7, 2009
    Assignee: Trigen GmbH
    Inventors: Steffen Massberg, Meinrad Gawaz, Andreas Bültmann, Götz Münch, Martin Ungerer, Mario Peluso
  • Use of EDG2 receptor in an animal model of heart failure
    Patent number: 7169612
    Abstract: Mammals and myocardial mammal cells transformed with G protein coupled receptor EDG2 are presented for use in an animal model for heart failure.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: January 30, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Evi Kostenis, Paulus Wohlfart, Jochen Huber, Kai Rosport, Andreas Bueltmann, Christine Baumgartner, Götz Muench, Martin Ungerer
  • Use of EDG2 receptor in an animal model of heart failure
    Publication number: 20040132182
    Abstract: Mammals and myocardial mammal cells transformed with G protein coupled receptor EDG2 are presented for use in an animal model for heart failure.
    Type: Application
    Filed: November 12, 2003
    Publication date: July 8, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Evi Kostenis, Paulus Wohlfart, Jochen Huber, Kai Rosport, Andreas Bueltmann, Christine Baumgartner, Gotz Muench, Martin Ungerer